While approvals may slip from last year's record-breaking tally, ANDA submissions remained on pace to slightly exceed the FY 2019 total, according to data through April. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
